Skip to main content
SK Bioscience Co.,Ltd logo

SK Bioscience Co.,Ltd — Investor Relations & Filings

Ticker · 302440 ISIN · KR7302440003 KO Manufacturing
Open in API
Filings indexed 381 across all filing types
Latest filing 2025-03-17 Audit Report / Informat…
Country KR South Korea
Listing KO 302440

About SK Bioscience Co.,Ltd

https://www.skbioscience.com/

SK Bioscience is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines and biological products. Spun off from SK Chemicals in 2018, the company develops its own pipeline of vaccines, including cell-culture-based influenza vaccines and a COVID-19 vaccine, utilizing its established R&D and production platforms. In addition to its proprietary products, SK Bioscience provides global Contract Development and Manufacturing Organization (CDMO) services, offering end-to-end support from process development to large-scale commercial manufacturing for international partners. The company is dedicated to promoting public health by providing innovative preventative solutions to address global health challenges.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from SK Bioscience titled 'Submission of Audit Report' (감사보고서 제출). It provides a summary of the audit opinion (unqualified/appropriate) and key financial data (assets, liabilities, revenue, profit/loss) for the fiscal year ending 2024-12-31. While it contains financial data, it is a formal notification of the audit report's submission to the regulatory body (KRX) rather than the full annual report itself. According to the 'Menu vs Meal' rule, this is a report publication announcement regarding the audit results. FY 2024
2025-03-17 Korean
사업보고서 (2024.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for SK Bioscience, covering the fiscal year 2024. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. While it contains financial data, it is specifically structured as an audit report package rather than a standard quarterly or annual report (10-K/IR). According to the provided definitions, standalone audit reports and results of financial statements are classified under 'AR'. FY 2024
2025-03-17 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings Classification · 1% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by SK Bioscience. This is a mandatory regulatory filing in South Korea regarding corporate group structure, inter-company transactions, and debt guarantees. Since it is a specific regulatory disclosure required by the Fair Trade Commission and does not fit into financial reporting categories like 10-K or IR, it falls under the general regulatory filing category.
2025-02-28 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for SK Bioscience. It contains the meeting agenda, voting procedures, electronic voting information, and detailed reports on board activities, remuneration, and related-party transactions. This document is a formal proxy statement and meeting notice sent to shareholders to inform them of the upcoming AGM and solicit their votes, which aligns with the definition of a Proxy Solicitation & Information Statement.
2025-02-25 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Reference Document) for SK Bioscience. It contains detailed information regarding the upcoming Annual General Meeting (AGM), including the date, agenda items (approval of financial statements, appointment of directors, etc.), and instructions for shareholders to exercise their voting rights via proxy or electronic voting. This document is a standard regulatory filing in Korea used to solicit proxies for shareholder meetings, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-02-25 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by SK Bioscience. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation/notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2025-02-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.